Message from the Chief Investigator
The Palliative Care Clinical Studies Collaborative (PaCCSC) is a team of outstanding clinicians who follow rigorous processes and procedures to ensure that the highest quality evidence can directly better inform decisions about clinical care. Our dedicated and enthusiastic investigators from established and new sites carefully conduct clinical trials. Because of this, the PaCCSC team is at the forefront of clinical trial research in palliative care across the world. Their drive and commitment to improving the care of patients generates the energy and momentum required to maintain PaCCSC and the work that we are doing.
Supporting access to appropriate medicines to help optimise comfort and function in the face of a life-limiting illness is a key focus of the Australian Government’s National Palliative Care Program. The commitment of the Australian Government to improving palliative care nationally has enabled us to gain a better understanding of the balance of benefits and harms of many interventions in this population.
The PaCCSC research program impacts the quality of care for the tens of thousands of patients with a life-limiting illness in Australia and around the world each year. Without the participation of patients and their caregivers, PaCCSC would not be the success it is. I would like to thank each and every person who has participated and their families for taking time at a very crucial part of life to reach out and help others because of their willingness to contribute to this important process of improving the quality of care.
PaCCSC studies are influencing clinical practice and improving the care of people at the end of life on a daily basis. We look forward to continuing to deliver more refined care to our palliative care patients nationally and around the world.
Professor David Currow FAHMS
Chief Investigator, PaCCSC